TrialAlzheimer's research & therapy2016
A single dose of the γ-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Mikko Hölttä et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it